Skip to main content
. 2011 May 17;104(12):1882–1889. doi: 10.1038/bjc.2011.166

Figure 1.

Figure 1

Immunohistochemical and western blotting analyses of GalNAc-T6 expressions in well-differentiated pancreatic cancer sample ( × 200) and PANC1 cell line after incubation of an anti-GalNAc-T6 polyclonal antibody with or without synthesised peptides of GalNAc-T6. IHC, immunohistochemistry; WB, western blotting. Bar, 100 μm. GalNAc-T6 expression is completely abolished with peptide.